| MAPK1 |
MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 |
LNK |
SH2B3, LNK: SH2B adapter protein 3 |
19.750 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
LNK |
SH2B3, LNK: SH2B adapter protein 3 |
19.750 |
Evidence |
|
| ERBB3 |
ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor |
PTPRS |
PTPRS: Receptor-type tyrosine-protein phosphatase S precursor |
19.750 |
Evidence |
|
| ERBB3 |
ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor |
PTPRJ |
PTPRJ, DEP1: Receptor-type tyrosine-protein phosphatase eta precursor |
19.750 |
Evidence |
|
| RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
RIN1 |
RIN1: Ras and Rab interactor 1 |
19.750 |
Evidence |
|
| VCAM1 |
VCAM1, L1CAM: Vascular cell adhesion protein 1 precursor |
ICAM3 |
ICAM3: Intercellular adhesion molecule 3 precursor |
19.750 |
Evidence |
|
| PTPN2 |
PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 |
PTPRC |
PTPRC, RP11-553K8.4-001, hCG_1811178: Protein tyrosine phosphatase, receptor typ |
19.750 |
Evidence |
|
| PTPN2 |
PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 |
CSF2RB |
CSF2RB, IL3RB, IL5RB: Cytokine receptor common beta chain precursor |
19.750 |
Evidence |
|
| PTPN2 |
PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 |
FGFR3 |
FGFR3, JTK4: Fibroblast growth factor receptor 3 precursor |
19.750 |
Evidence |
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
PTPN6 |
PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 |
19.750 |
Evidence |
|
| CEACAM1 |
CEACAM1, BGP, BGP1: Carcinoembryonic antigen-related cell adhesion molecule 1 pr |
ERBB3 |
ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor |
19.750 |
Evidence |
|
| BMP1 |
IPI00009054 |
HLA-DMA |
DMA, HLA-DMA, DAQB-96B10.1-001, DASS-67H14.8-001, XXbac-BCX136A3.1-001, XXbac-BP |
19.750 |
Evidence |
|
| PABPC1 |
PABPC1, PAB1, PABP1, PABPC2: Polyadenylate-binding protein 1 |
HNRPC |
HNRPC: Heterogeneous nuclear ribonucleoproteins C1/C2 |
19.750 |
Evidence |
|
| BCL2 |
BCL2: Apoptosis regulator Bcl-2 |
PSEN1 |
PSEN1, AD3, PS1, PSNL1: Presenilin-1 |
19.750 |
Evidence |
|
| SP1 |
SP1, TSFP1: Transcription factor Sp1 |
ZNF295 |
ZNF295, KIAA1227, ZBTB21: Zinc finger protein 295 |
19.750 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
MAP4K1 |
MAP4K1, HPK1: Mitogen-activated protein kinase kinase kinase kinase 1 |
19.750 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
NEK3 |
NEK3: Serine/threonine-protein kinase Nek3 |
19.750 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
SNCA |
SNCA, NACP, PARK1: Alpha-synuclein |
19.750 |
Evidence |
|
| INSR |
INSR: Insulin receptor precursor |
PTPRE |
PTPRE: Receptor-type tyrosine-protein phosphatase epsilon precursor |
19.750 |
Evidence |
|
| INSR |
INSR: Insulin receptor precursor |
AXL |
AXL, UFO: Tyrosine-protein kinase receptor UFO precursor |
19.750 |
Evidence |
|
| JUN |
JUN: Transcription factor AP-1 |
MAPK15 |
IPI00395861 |
19.750 |
Evidence |
|
| PRKCG |
PRKCG, PKCG: Protein kinase C gamma type |
SNCA |
SNCA, NACP, PARK1: Alpha-synuclein |
19.750 |
Evidence |
|
| ERBB2 |
ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor |
PTPRS |
PTPRS: Receptor-type tyrosine-protein phosphatase S precursor |
19.750 |
Evidence |
|
| ERBB2 |
ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor |
IL6ST |
IL6ST: Interleukin-6 receptor subunit beta precursor |
19.750 |
Evidence |
|
| RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
MINK1 |
MAP4K6, MINK1, MINK: Misshapen-like kinase 1 |
19.750 |
Evidence |
|